SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-334650
Filing Date
2013-08-14
Accepted
2013-08-14 17:33:40
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d549997d10q.htm 10-Q 366251
2 EX-31.1 d549997dex311.htm EX-31.1 9305
3 EX-31.2 d549997dex312.htm EX-31.2 9290
4 EX-32.1 d549997dex321.htm EX-32.1 3370
5 EX-32.2 d549997dex322.htm EX-32.2 3355
  Complete submission text file 0001193125-13-334650.txt   4985660

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cprx-20130630.xml EX-101.INS 482400
7 XBRL TAXONOMY EXTENSION SCHEMA cprx-20130630.xsd EX-101.SCH 45586
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cprx-20130630_cal.xml EX-101.CAL 47773
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cprx-20130630_def.xml EX-101.DEF 99048
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cprx-20130630_lab.xml EX-101.LAB 301185
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cprx-20130630_pre.xml EX-101.PRE 191922
Mailing Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 1500 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICAL PARTNERS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33057 | Film No.: 131038193
SIC: 2834 Pharmaceutical Preparations